TUCSON
520.748.4400
About Us
Professional Staff
Board of Directors
Careers
Contact Us
Frederick Gardner
Cottrell Foundation
Successes
Ventures
Biotechnology
Medical Devices
Other
Historic Investments
Technologies
The CH2 Domain Scaffold – ABDURINS™
Deimmunized Sarcin Ribotoxin
Endotoxin-free ClearColi™ Expression System
Fibronectin Artificial Antibody Scaffold
Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)
Pichia Classic Expression Platform
Pichia GlyoSwitch™ Protein Expression System
Shingles Vaccine Antigen
Ultrasound Tissue Harmonic Imaging
VIMPAT® (lacosamide) for Treatment of Epileptic Seizures
Innovate With Us
News & Events
Home
»
News & Events
Elizabeth Hickman to Succeed Tim Scott as AustinPx CEO
3.6.2024
Complete Genomics and seqWell Announce Codevelopment Partnership
2.9.2024
TD2 Expands Preclinical and Clinical Services by Acquiring Flow Contract Site Laboratory (FCSL)
2.1.2024
AustinPx Partners with Microsize on KinetiSol® Technology
2.1.2024
S2 Genomics Raises Series A Round Led by RCT and BroadOak
1.24.2024
Pheon Therapeutics Appoints Cyrus Mozayeni, MD as CEO
7.25.2023
Introducing Motive: FDA-Cleared Knee Pain Relief Therapy
7.10.2023
Pheon Therapeutics enters into license agreement with Biocytogen Pharmaceuticals
7.5.2023
C-Path’s TRxA Accelerates its First Drug Development Projects with Support from RCT’s Cottrell Foundation
6.28.2023
BioTools Innovator Announces 2023 Cohort
6.6.2023
Post navigation
←
Older posts
News by Year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
From concept
to market
Innovate with us ›